Capecitabine: new indication. Advanced-stage gastric cancer: oral route for some patients. Risk of palmoplantar erythrodysaesthesia
Prescrire International 17(95): 107
2008
ISSN/ISBN: 1167-7422 PMID: 18627118 Document Number: 617293
Document emailed within 1 workday
Related Documents
Qian, J.; Qin, S.-k.; Mei, J.-f.; Chen, Y.-x.; Shao, Z.-j.; He, Z.-m. 2004: Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer Zhonghua Zhong Liu Za Zhi 26(12): 746-748Maruyama, M.; Ebuchi, M.; Takashima, K.; Maruyama, S.; Hasegawa, K.; Ohbe, M.; Koide, A.; Shinoura, Y.; Katoh, K. 2004: MTX/CDDP/5-FU double modulation intra-peritoneal chemotherapy for advanced and metastatic gastric cancer--comparison with intra-aortic route and intra-venous route Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1714-1716
Oneda, Y.; Tamura, S.; Murakami, K.; Takeno, A.; Kuwahara, R.; Akiyama, Y.; Sakamoto, T.; Inatome, J.; Naito, A.; Katsura, Y.; Ohmura, Y.; Kagawa, Y.; Egawa, C.; Takeda, Y.; Kato, T. 2016: A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine, Cisplatin, and Trastuzumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2202-2204
Kuga, Y.; Kitamura, S.; Okanobu, H.; Sakimoto, H.; Nishida, T. 2016: A Case of HER2-Positive Advanced Gastric Cancer with Multiple Liver Metastases Effectively Treated with Trastuzumab, Capecitabine, and Cisplatin Combination Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(10): 1211-1214
Takahashi, M.; Fujimoto, S.; Kobayashi, K.; Takai, M.; Endoh, F.; Ohkubo, H. 1995: Indication for splenectomy combined with total gastrectomy for gastric cancer: analysis of data on 249 gastric cancer patients Hepato-Gastroenterology 42(3): 230-233
Guarnieri, A.; Tucci, E.; D'Aniello, C.; Carli, A.; Mariani, L.; De Stefano, A.; Nardi, P. 1984: Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(5): 320-323
Osti, M.Falchetto.; Agolli, L.; Bracci, S.; Monaco, F.; Tubin, S.; Minniti, G.; De Sanctis, V.; Enrici, R.Maurizi. 2012: Adjuvant chemoradiation with 5-fluorouracil or capecitabine in patients with gastric cancer after D2 nodal dissection Anticancer Research 32(4): 1397-1402
Sato, Y.; Yajima, K.; Kosugi, S-ichi.; Muneoka, Y.; Ichikawa, H.; Hanyu, T.; Sakamoto, K.; Ishikawa, T.; Wakai, T. 2014: Current status of adjuvant chemotherapy in patients with p-Stage II and p-Stage III gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(8): 961-964
Wiesenthal, A.; Matherne, R.; Gibson, B. 2012: Capecitabine-induced systemic lupus erythematosus and palmoplantar erythrodysesthesia Journal of Drugs in Dermatology: Jdd 11(6): 769-771
Tsuyuki, S.; Kawaguchisakita, N.; Tsubota, Y.; Ukikusa, M.; Kohno, Y. 2010: More effective positioning of capecitabine for advanced and metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(4): 649-653
Veerasarn, V.; Boonnuch, W.; Chinswangwatanakul, V.; Lohsiriwat, D.; Mahamadsolaeh, P. 2008: Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day Journal of the Medical Association of Thailand 91(10): 1583-1588
Omatsu, T.; Ichikawa, H.; Kawahito, Y.; Ashihara, E.; Yamamoto, A.; Kadoya, M.; Takegami, T.; Takanashi, Y.; Naito, Y.; Yoshida, N.; Sugino, S.; Yoshikawa, T. 2003: A case of advanced gastric cancer with bone metastases and DIC responding to oral administration of TS-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(6): 869-873
Veerasarn, V.; Phromratanapongse, P.; Lorvidhaya, V.; Lertsanguansinchai, P.; Lertbutsayanukul, C.; Panichevaluk, A.; Boonnuch, W.; Chinswangwatanakul, V.; Lohsiriwat, D.; Rojanasakul, A.; Thavichaigarn, P.; Jivapaisarnpong, P. 2006: Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase i trial) Journal of the Medical Association of Thailand 89(11): 1874-1884
Scutariu, M.Mihaela.; Voroneanu, M. 2006: Current aspects of risk factors in early stage cancer of the oral cavity Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 110(2): 425-431
Jin, J.; Li, Y-Xiong.; Liu, Y-Ping.; Wang, W-Hu.; Li, T.; Li, N.; Song, Y-wen. 2006: Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer Zhonghua Zhong Liu Za Zhi 28(5): 393-396
Uysal, M.; Ozdogan, M.; Kargi, A.; Gunduz, S.; Sezgin Goksu, S.; Murat Tatli, A.; Arslan, D.; Mutlu, H.; Senol Coskun, H.; Bozcuk, H. 2014: Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 980-984
Tanneberger, S.; Pannuti, F.; Mirri, R.; Panetta, A.; Mariano, P.; Giordani, S.; Strocchni, E.; Farabegoli, G. 1997: Home hospital for advanced stage cancer patients: costs and benefits Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(2): 117-123
Tanneberger, S.; Pannuti, F.; Mirri, R.; Panetta, A.; Mariano, P.; Giordani, S.; Strocchni, E.; Farabegoli, G. 1997: Home hospital for advanced stage cancer patients: costs and benefits Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(2): 117-123
Clark, M.M.; Vickers, K.S.; Hathaway, J.C.; Smith, M.; Looker, S.A.; Petersen, L.R.; Pinto, B.M.; Rummans, T.A.; Loprinzi, C.L. 2007: Physical activity in patients with advanced-stage cancer actively receiving chemotherapy Journal of Supportive Oncology 5(10): 487-493
Ji, J.; Liang, H.; Zhan, Y.; Liu, Y.; He, Y.; Ye, Y.; Sun, Y.; Huang, C.; Yan, M.; Shi, Y.; Wu, A. 2014: Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): Chinese subgroup analysis Zhonghua Wei Chang Wai Ke Za Zhi 17(2): 133-138